Electrophysiologic study: its predictive value for ventricular arrhythmias.

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Structural heart disease increases risk of ventricular arrhythmias.
• Electrophysiologic studies (EPS) assess arrhythmia risk.
• Implantable cardioverter-defibrillators (ICDs) treat life-threatening ventricular arrhythmias.

Purpose of the Study:

• To evaluate the predictive value of EPS findings before ICD implantation.
• To determine if inducible ventricular tachycardia (VT) characteristics predict future arrhythmic events and ICD therapy.

Main Methods:

• Retrospective analysis of 315 patients with inducible VT undergoing EPS before ICD placement.
• Follow-up data collected for at least 1 month, assessing VT cycle length, intervals, and QRS duration.
• Arrhythmia events and ICD therapies were recorded and analyzed.

Main Results:

• Patients with inducible VT cycle length ≥240 msec experienced their first arrhythmia significantly earlier than those with <240 msec (P<0.032).
• A VT cycle length ≥240 msec was identified as a predictor of earlier appropriate ICD therapy.
• No significant difference was found in other electrophysiologic parameters or PR/QT intervals.

Conclusions:

• Inducible VT with a cycle length ≥240 msec is a significant predictor of earlier appropriate ICD therapy in patients with structural heart disease.
• These findings support considering ICD programming for antitachycardia pacing in this patient subgroup.
• EPS-derived VT cycle length may aid in risk stratification and personalized patient management.